Fortrea Holdings (FTRE) Other financing activities (2024 - 2025)

Fortrea Holdings (FTRE) reported Other financing activities of $600000.0 for Q1 2025, down 14.29% quarter-over-quarter from $700000.0 in Q4 2024.

Fortrea Holdings (FTRE) Other financing activities (2024 - 2025) Analysis & Trends

Fortrea Holdings has reported Other financing activities for 2 years, with the latest figure at $600000.0 in Q1 2025.

For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to $600000.0; the trailing twelve-month figure through Dec 2025 stood at $600000.0 (down 14.29% YoY), and the FY2025 full-year result was $600000.0, down 14.29% from the prior year.
Other financing activities for Q1 2025 stood at $600000.0, down from $700000.0 in the prior quarter.
The five-year high for Other financing activities was $700000.0 in Q4 2024, with the low at $600000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Fortrea Holdings	1.43 Bn	1.28 Bn	123.60 Mn

Download Data